Gene therapy scores against cancer
- 1 August 2000
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 6 (8), 862-863
- https://doi.org/10.1038/78610
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNature Medicine, 2000
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsNature Medicine, 1997
- T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 YearsScience, 1995
- Inhibition of p53 transactivation required for transformation by adenovirus early 1B proteinNature, 1992
- Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene TransductionNew England Journal of Medicine, 1990
- Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfectionVirology, 1987